MCF Advisors LLC Boosts Stock Holdings in Humana Inc. (NYSE:HUM)

MCF Advisors LLC grew its holdings in Humana Inc. (NYSE:HUM) by 5.4% in the 2nd quarter, HoldingsChannel reports. The firm owned 4,071 shares of the insurance provider’s stock after buying an additional 208 shares during the quarter. MCF Advisors LLC’s holdings in Humana were worth $1,522,000 as of its most recent SEC filing.

Other hedge funds have also recently modified their holdings of the company. Intech Investment Management LLC grew its position in shares of Humana by 46.2% in the 4th quarter. Intech Investment Management LLC now owns 42,287 shares of the insurance provider’s stock worth $19,359,000 after buying an additional 13,356 shares during the last quarter. AdvisorShares Investments LLC acquired a new position in shares of Humana during the fourth quarter worth $421,000. Sei Investments Co. lifted its holdings in shares of Humana by 0.4% during the 1st quarter. Sei Investments Co. now owns 61,897 shares of the insurance provider’s stock valued at $21,462,000 after purchasing an additional 264 shares during the last quarter. Cetera Advisors LLC boosted its position in shares of Humana by 472.1% in the 1st quarter. Cetera Advisors LLC now owns 10,098 shares of the insurance provider’s stock worth $3,501,000 after purchasing an additional 8,333 shares in the last quarter. Finally, Cetera Investment Advisers increased its position in Humana by 249.0% during the 1st quarter. Cetera Investment Advisers now owns 20,945 shares of the insurance provider’s stock valued at $7,262,000 after buying an additional 14,944 shares in the last quarter. Hedge funds and other institutional investors own 92.38% of the company’s stock.

Wall Street Analyst Weigh In

Several equities research analysts have weighed in on HUM shares. Morgan Stanley initiated coverage on Humana in a report on Monday, June 24th. They issued an “equal weight” rating and a $374.00 price target for the company. Bank of America upped their price target on shares of Humana from $342.00 to $376.00 and gave the company a “neutral” rating in a research note on Monday, May 20th. JPMorgan Chase & Co. lifted their price objective on shares of Humana from $332.00 to $396.00 and gave the stock a “neutral” rating in a research note on Wednesday, August 21st. Piper Sandler began coverage on Humana in a research report on Wednesday, June 26th. They issued an “overweight” rating and a $392.00 target price on the stock. Finally, Truist Financial lifted their price target on Humana from $355.00 to $400.00 and gave the stock a “hold” rating in a research report on Monday, July 15th. Thirteen research analysts have rated the stock with a hold rating and nine have given a buy rating to the company’s stock. According to MarketBeat, Humana currently has an average rating of “Hold” and an average price target of $398.70.

Humana Stock Performance

HUM opened at $364.81 on Friday. The firm has a fifty day moving average price of $367.99 and a 200 day moving average price of $347.34. Humana Inc. has a 1 year low of $298.61 and a 1 year high of $530.54. The stock has a market cap of $43.96 billion, a P/E ratio of 22.72, a P/E/G ratio of 3.16 and a beta of 0.51. The company has a debt-to-equity ratio of 0.70, a current ratio of 1.66 and a quick ratio of 1.66.

Humana (NYSE:HUM) last issued its quarterly earnings data on Wednesday, July 31st. The insurance provider reported $6.96 earnings per share for the quarter, topping analysts’ consensus estimates of $5.89 by $1.07. Humana had a net margin of 1.53% and a return on equity of 16.12%. The business had revenue of $29.54 billion during the quarter, compared to the consensus estimate of $28.52 billion. During the same quarter in the prior year, the firm posted $8.94 earnings per share. The company’s revenue was up 10.4% compared to the same quarter last year. Equities research analysts anticipate that Humana Inc. will post 16.14 earnings per share for the current year.

Humana Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Friday, October 25th. Shareholders of record on Monday, September 30th will be given a dividend of $0.885 per share. The ex-dividend date of this dividend is Monday, September 30th. This represents a $3.54 dividend on an annualized basis and a yield of 0.97%. Humana’s dividend payout ratio is currently 22.04%.

Humana Company Profile

Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.